🍽️ sulfaphenazole (antibiotic)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Pharmacological Properties: Sulfaphenazole is primarily used in laboratory research to inhibit the activity of specific cytochrome P450 enzymes, particularly CYP2C9. This enzyme is involved in the metabolism of various drugs, including anticoagulants (e.g., warfarin), nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antiepileptic medications.

  2. Cytochrome P450 Inhibition: By inhibiting CYP2C9, sulfaphenazole can affect the metabolism and clearance of drugs that are substrates for this enzyme. This inhibition may lead to alterations in the pharmacokinetics and efficacy of co-administered medications, potentially increasing their plasma concentrations and prolonging their effects.

  3. Drug-Drug Interactions: Sulfaphenazole's ability to inhibit cytochrome P450 enzymes, particularly CYP2C9, can result in clinically significant drug interactions when co-administered with other medications metabolized by the same enzyme system. These interactions may necessitate dose adjustments or careful monitoring to prevent adverse effects or therapeutic failure.

  4. Research Tool: Due to its potent inhibitory effects on CYP2C9, sulfaphenazole is commonly used in preclinical studies and in vitro experiments to investigate drug metabolism, drug-drug interactions, and the pharmacokinetics of various compounds. It serves as a valuable tool for understanding the role of CYP2C9 in drug metabolism and pharmacokinetics.

  5. Limited Clinical Use: Sulfaphenazole is not typically used in clinical practice for therapeutic purposes due to its primarily research-oriented application and potential for significant drug interactions. Its use is largely confined to laboratory settings, where it is employed as a selective inhibitor of CYP2C9 to elucidate metabolic pathways and drug interactions.

  6. Safety Considerations: While sulfaphenazole is generally well-tolerated in laboratory research settings, its use in humans is limited and primarily restricted to investigational studies. Like other medications, sulfaphenazole may be associated with adverse effects, although these are less relevant in the context of its intended use as a research tool rather than a therapeutic agent.

  7. Consultation with Healthcare Providers: Individuals participating in research studies involving sulfaphenazole or other pharmacological agents should consult with healthcare providers and researchers for appropriate guidance regarding the risks, benefits, and safety considerations associated with the study protocol.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of sulfaphenazole (antibiotic) On Probiotics

Bacteria Impacted by sulfaphenazole (antibiotic)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

Impact of sulfaphenazole (antibiotic) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]